An anoikis-related gene signature predicts prognosis and immunotherapy response, and identifies CCAR2 as a therapeutic target in triple-negative breast cancer.
Saved in:
| Title: | An anoikis-related gene signature predicts prognosis and immunotherapy response, and identifies CCAR2 as a therapeutic target in triple-negative breast cancer. |
|---|---|
| Authors: | Chen Y; College of Clinical Medicine, Dali University, Dali, Yunnan, China., Lu X; College of Clinical Medicine, Dali University, Dali, Yunnan, China., Zhang L; College of Basic Medicine, Dali University, Dali, Yunnan, China., Li Y; College of Clinical Medicine, Dali University, Dali, Yunnan, China., Chen H; College of Basic Medicine, Dali University, Dali, Yunnan, China., Luo L; College of Clinical Medicine, Dali University, Dali, Yunnan, China., Pan Y; College of Clinical Medicine, Dali University, Dali, Yunnan, China.; Department of Pathology, The First Affiliated Hospital of Dali University, Dali, Yunnan, China., Gao B; College of Clinical Medicine, Dali University, Dali, Yunnan, China.; Department of Pathology, The First Affiliated Hospital of Dali University, Dali, Yunnan, China. |
| Source: | Frontiers in immunology [Front Immunol] 2026 May 20; Vol. 17, pp. 1808490. Date of Electronic Publication: 2026 May 20 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1664-3224 |
|---|---|
| DOI: | 10.3389/fimmu.2026.1808490 |
